HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noboru Yamamoto Selected Research

Creatinine

12/2023Pimitespib for the treatment of advanced gastrointestinal stromal tumors and other tumors.
1/2019First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors.
11/2013Short hydration in chemotherapy containing cisplatin (≥75 mg/m2) for patients with lung cancer: a prospective study.
3/2012A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors.
12/2009A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noboru Yamamoto Research Topics

Disease

187Neoplasms (Cancer)
04/2024 - 01/2002
104Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 02/2002
29Disease Progression
03/2024 - 07/2006
21Lung Neoplasms (Lung Cancer)
06/2023 - 08/2005
20Neutropenia
10/2020 - 02/2005
17Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 06/2004
14Diarrhea
01/2021 - 11/2006
12Exanthema (Rash)
03/2024 - 01/2010
12Nausea
12/2023 - 06/2003
10Neoplasm Metastasis (Metastasis)
07/2023 - 05/2007
10Carcinoma (Carcinomatosis)
01/2022 - 08/2005
9Hypertension (High Blood Pressure)
01/2022 - 11/2006
8Thymoma (Thymic Carcinoma)
03/2024 - 08/2011
8Thrombocytopenia (Thrombopenia)
12/2015 - 10/2005
7Adenocarcinoma of Lung
12/2020 - 12/2008
7Leukopenia
12/2015 - 10/2005
6Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 07/2004
6Vomiting
01/2020 - 06/2003
5Melanoma (Melanoma, Malignant)
11/2023 - 10/2016
5Fatigue
01/2021 - 06/2003
5Proteinuria
01/2018 - 11/2009
4Breast Neoplasms (Breast Cancer)
03/2024 - 06/2012
4Anorexia
01/2021 - 08/2010
4Fever (Fevers)
12/2020 - 07/2006
4Thymus Neoplasms (Thymus Neoplasm)
06/2020 - 08/2011
4Stomatitis
05/2020 - 08/2010
4Sleepiness
01/2020 - 08/2010
3Biliary Tract Neoplasms (Biliary Tract Cancer)
03/2024 - 01/2022
3Stomach Neoplasms (Stomach Cancer)
01/2024 - 01/2018
3Dermatitis
11/2023 - 09/2013
3Pruritus (Itching)
11/2023 - 10/2012
3Pneumonia (Pneumonitis)
10/2023 - 01/2012
3Body Weight (Weight, Body)
05/2023 - 12/2012
3Sarcoma (Soft Tissue Sarcoma)
01/2023 - 06/2012
3Lymphoma (Lymphomas)
01/2022 - 12/2020
3Drug-Related Side Effects and Adverse Reactions
12/2021 - 04/2005
3Radiation Pneumonitis
01/2020 - 07/2006
3Febrile Neutropenia
01/2020 - 07/2014

Drug/Important Bio-Agent (IBA)

24ErbB Receptors (EGF Receptor)IBA
06/2023 - 10/2005
24Cisplatin (Platino)FDA LinkGeneric
10/2021 - 02/2002
21PlatinumIBA
04/2024 - 10/2003
20NivolumabIBA
01/2024 - 11/2016
20Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 12/2003
19Biomarkers (Surrogate Marker)IBA
04/2024 - 04/2011
16Tyrosine Kinase InhibitorsIBA
06/2023 - 03/2008
14pembrolizumabIBA
04/2024 - 01/2020
14Immune Checkpoint InhibitorsIBA
01/2024 - 03/2016
14Irinotecan (Camptosar)FDA LinkGeneric
01/2017 - 01/2002
13Carboplatin (JM8)FDA LinkGeneric
01/2017 - 09/2005
12Alanine Transaminase (SGPT)IBA
03/2024 - 12/2003
12Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2023 - 03/2008
11Gefitinib (Iressa)FDA Link
05/2020 - 07/2004
10Monoclonal AntibodiesIBA
03/2024 - 03/2014
10amrubicinIBA
11/2019 - 03/2010
8LigandsIBA
01/2024 - 01/2016
8Docetaxel (Taxotere)FDA Link
01/2023 - 10/2003
8B7-H1 AntigenIBA
03/2022 - 09/2015
8Phosphotransferases (Kinase)IBA
12/2021 - 05/2011
8Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2021 - 10/2005
7Proteins (Proteins, Gene)FDA Link
03/2024 - 04/2006
6lenvatinibIBA
03/2024 - 04/2011
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2023 - 11/2009
6GemcitabineFDA Link
06/2013 - 02/2002
5AntibodiesIBA
04/2024 - 09/2004
5eribulinFDA Link
01/2024 - 01/2021
5CreatinineIBA
12/2023 - 12/2009
5Pemetrexed (MTA)FDA Link
08/2023 - 07/2010
5CrizotinibIBA
07/2023 - 08/2016
5Bevacizumab (Avastin)FDA Link
06/2023 - 10/2014
4Immunoconjugates (Immunoconjugate)IBA
03/2024 - 01/2021
4durvalumabIBA
10/2023 - 05/2019
4osimertinibIBA
05/2023 - 07/2017
4Etoposide (VP 16)FDA LinkGeneric
01/2023 - 04/2014
4EnzymesIBA
01/2021 - 02/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 02/2016
4Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 08/2006
4Olanzapine (Zyprexa)FDA Link
01/2020 - 02/2015
4amrubicinolIBA
11/2019 - 03/2010
3atezolizumabIBA
03/2024 - 10/2016
3Surface Antigens (Surface Antigen)IBA
03/2024 - 01/2022
3Cytotoxins (Cytolysins)IBA
03/2024 - 03/2016
3dabrafenibIBA
03/2024 - 01/2018
3AntigensIBA
12/2023 - 04/2021
3BilirubinIBA
11/2023 - 05/2007
3Anaplastic Lymphoma KinaseIBA
07/2023 - 01/2017
3Investigational DrugsIBA
01/2023 - 03/2016
3Programmed Cell Death 1 ReceptorIBA
01/2023 - 11/2016
3RamucirumabIBA
01/2023 - 04/2017
3alectinibIBA
05/2022 - 01/2017
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
07/2021 - 01/2020
3vandetanib (ZD6474)IBA
01/2021 - 11/2006

Therapy/Procedure

82Therapeutics
03/2024 - 07/2004
68Drug Therapy (Chemotherapy)
03/2024 - 02/2002
17Radiotherapy
01/2021 - 07/2004
15Chemoradiotherapy
10/2023 - 03/2007
7Precision Medicine
12/2023 - 09/2018
6Immunotherapy
04/2024 - 01/2018
6Genomic Medicine
12/2023 - 09/2018
4Intravenous Infusions
02/2016 - 04/2008
3Molecular Targeted Therapy
01/2023 - 12/2015